Advertisement
Australia markets closed
  • ALL ORDS

    8,012.10
    +1.60 (+0.02%)
     
  • AUD/USD

    0.6670
    -0.0003 (-0.05%)
     
  • ASX 200

    7,769.40
    -0.30 (-0.00%)
     
  • OIL

    81.68
    +0.11 (+0.13%)
     
  • GOLD

    2,353.90
    +7.00 (+0.30%)
     
  • Bitcoin AUD

    99,135.22
    +1,533.73 (+1.57%)
     
  • CMC Crypto 200

    1,374.17
    -8.49 (-0.61%)
     

Swedish Growth Companies With High Insider Ownership In June 2024

As of June 2024, the Swedish market reflects a cautious optimism amidst a complex global economic landscape marked by fluctuating inflation rates and policy adjustments in Europe. In this environment, growth companies with high insider ownership stand out as potentially resilient investments, as significant insider stakes often align leadership interests with shareholder value creation.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

BioArctic (OM:BIOA B)

35.1%

50.5%

Sileon (OM:SILEON)

33.3%

109.3%

InCoax Networks (OM:INCOAX)

18%

104.9%

KebNi (OM:KEBNI B)

37.8%

90.4%

Calliditas Therapeutics (OM:CALTX)

11.6%

53%

edyoutec (NGM:EDYOU)

14.6%

63.1%

Egetis Therapeutics (OM:EGTX)

17.6%

98.2%

Yubico (OM:YUBICO)

37.5%

42.5%

SaveLend Group (OM:YIELD)

24.9%

103.4%

Click here to see the full list of 82 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

ADVERTISEMENT

Here's a peek at a few of the choices from the screener.

Medicover

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Medicover AB (publ) operates in the healthcare and diagnostics sector, offering services primarily in Poland and Sweden, as well as internationally, with a market capitalization of SEK 29.91 billion.

Operations: Medicover's revenue is primarily derived from its Healthcare Services and Diagnostic Services segments, generating €1.26 billion and €585.20 million respectively.

Insider Ownership: 11.1%

Medicover, a Swedish growth company with high insider ownership, is trading at 50.8% below its estimated fair value, suggesting potential undervaluation. The company recently reported significant earnings growth of 1492.9% over the past year and expects substantial future growth with earnings forecasted to increase by 38.2% annually over the next three years. However, its revenue growth projection of 14.5% per year lags behind this earnings surge and is slower than the desired 20% annual benchmark for high-growth firms. Additionally, Medicover's interest payments are not well covered by earnings, indicating some financial strain despite robust profit increases and optimistic revenue guidance exceeding €2.2 billion for year-end 2025.

OM:MCOV B Earnings and Revenue Growth as at Jun 2024
OM:MCOV B Earnings and Revenue Growth as at Jun 2024

Pandox

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB is a Swedish hotel property company specializing in owning, operating, and leasing hotel properties, with a market capitalization of approximately SEK 34.86 billion.

Operations: The company generates revenue primarily through two segments: own operations, which brought in SEK 3.24 billion, and rental agreements, contributing SEK 3.76 billion.

Insider Ownership: 12.3%

Pandox, a Swedish company with high insider ownership, shows mixed financial health. While its earnings are set to increase significantly by 46.3% annually over the next three years, revenue growth remains modest at 2.2% per year, barely outpacing the Swedish market average of 2.1%. Recent results indicate a strong rebound with SEK 447 million in net income for Q1 2024 after a loss the previous year. However, challenges persist as dividends are poorly covered by earnings and interest payments strain finances.

OM:PNDX B Ownership Breakdown as at Jun 2024
OM:PNDX B Ownership Breakdown as at Jun 2024

Wallenstam

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Wallenstam AB (publ) is a Swedish property company with a market capitalization of approximately SEK 34.92 billion.

Operations: The company generates revenue primarily from its operations in Gothenburg and Stockholm, with SEK 1.89 billion and SEK 920 million respectively.

Insider Ownership: 35%

Wallenstam, despite its strong Q1 2024 performance with a significant increase in net income to SEK 333 million from SEK 48 million year-over-year, faces challenges. Its revenue growth forecast at 3% per year slightly outpaces the Swedish market average of 2.1%, yet its return on equity is expected to remain low at 4.6%. Additionally, there has been no substantial insider buying in the past three months, and interest payments are not well covered by earnings, reflecting some financial strain.

OM:WALL B Earnings and Revenue Growth as at Jun 2024
OM:WALL B Earnings and Revenue Growth as at Jun 2024

Summing It All Up

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:MCOV B OM:PNDX B and OM:WALL B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com